Nanoform Finland Oyj (HEL:NANOFH)
Finland · Delayed Price · Currency is EUR 0.8120
+0.0280 (3.57%)
Jul 17, 2026, 6:29 PM EET
Nanoform Finland Oyj Revenue
Nanoform Finland Oyj had revenue of 1.54M EUR in the quarter ending March 31, 2026, with 17.25% growth. This brings the company's revenue in the last twelve months to 5.25M, up 23.53% year-over-year. In the year 2025, Nanoform Finland Oyj had annual revenue of 5.02M with 37.10% growth.
Revenue (ttm)
5.25M
Revenue Growth
+23.53%
P/S Ratio
12.83
Revenue / Employee
38.99K
Employees
139
Market Cap
69.56M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.02M | 1.36M | 37.10% |
| Dec 31, 2024 | 3.66M | 1.10M | 42.75% |
| Dec 31, 2023 | 2.57M | -921.38K | -26.42% |
| Dec 31, 2022 | 3.49M | 1.53M | 78.42% |
| Dec 31, 2021 | 1.95M | 1.24M | 173.88% |
| Dec 31, 2020 | 713.68K | 433.68K | 154.89% |
| Dec 31, 2019 | 280.00K | -9.65K | -3.33% |
| Dec 31, 2018 | 289.65K | 44.05K | 17.93% |
| Dec 31, 2017 | 245.61K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orion Oyj | 1.95B |
| Terveystalo Oyj | 1.24B |
| Pihlajalinna Oyj | 613.23M |
| Revenio Group Oyj | 111.05M |
| Optomed Oyj | 16.43M |
| Biohit Oyj | 15.73M |
| Nexstim | 12.41M |
| Modulight Oyj | 10.43M |
Nanoform Finland Oyj News
- 2 months ago - Nanoform Finland Oyj Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Nanoform Finland Oyj Quarterly report: Q1 2026 - Filings
- 2 months ago - Nanoform Finland Oyj Slides: Q1 2026 - Filings
- 2 months ago - Nanoform Finland Oyj: Nanoform Q1 2026 report - Record first quarter revenue, income and gross margin, first exclusivity deal signed around our Biologics technology - Finanz Nachrichten
- 2 months ago - Nanoform Finland Oyj: Inside information: Nanoform Signs First Exclusivity Agreement for Ultra-High Concentration Subcutaneous Delivery - Finanz Nachrichten
- 4 months ago - Nanoform Finland Oyj: The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees - Finanz Nachrichten
- 5 months ago - Nanoform Finland Oyj Earnings Call Transcript: Q4 2025 - Transcripts
- 5 months ago - Nanoform Finland Oyj Annual report: Q4 2025 - Filings